MediFind
Condition

Acute Myelomonocytic Leukemia

Condition 101

What are the alternative names for Acute Myelomonocytic Leukemia?

  • AML-M4
  • Acute myeloblastic leukemia type 4
  • AML M4
  • AMMoL

Latest Research

Latest Advance
Study
  • Condition: Therapy-Related Myeloid Neoplasms
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Allogeneic Stem Cell Transplantation
  • Number of Patients: 12169
  • Published —
This study tested the safety and efficacy of using allogeneic stem cell transplantation to treat patients with therapy-related myeloid neoplasms.
Latest Advance
Study
  • Condition: Patients with Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN)
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation (allo-HSCT)
  • Number of Patients: 48
  • Published —
This study assessed the effectiveness of a new conditioning regimen comprising decitabine (Dec), busulfan (Bu), cyclophosphamide (Cy), fludarabine (Flu), and cytarabine (Ara-c) for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN).
Latest Advance
Study
  • Condition: Myelodysplastic syndrome and chronic myelomonocytic leukemia
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Decitabine-based conditioning regimen
  • Number of Patients: 22
  • Published —
The aim of the study was to assess the effectiveness and toxicity of decitabine-based conditioning regimen in patients with myelodysplastic syndrome (MDS), acute myeloid leukemia secondary to MDS (MDS-AML) or chronic myelomonocytic leukemia (CMML).
Latest Advance
Study
  • Condition: Juvenile Myelomonocytic Leukemia
  • Journal: Pediatric blood & cancer
  • Treatment Used: Azacitidine
  • Number of Patients: 1
  • Published —
This case reported on an infant with juvenile myelomonocytic leukemia treated with azacitidine.